These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 21315633

  • 1. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
    Tan A, Etit D, Bayol U, Altinel D, Tan S.
    Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
    [Abstract] [Full Text] [Related]

  • 2. Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution.
    Sahoo S, Hoda SA, Rosai J, DeLellis RA.
    Am J Clin Pathol; 2001 Nov; 116(5):696-702. PubMed ID: 11710686
    [Abstract] [Full Text] [Related]

  • 3. High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors.
    Raphael SJ, McKeown-Eyssen G, Asa SL.
    Mod Pathol; 1994 Apr; 7(3):295-300. PubMed ID: 7520169
    [Abstract] [Full Text] [Related]

  • 4. [Expression of Twist in papillary thyroid carcinomas and its roles in differential diagnosis].
    He CN, He L, Cheng JQ, Chen SC, Zhao HF, Zhai JP, Zhang J.
    Zhonghua Bing Li Xue Za Zhi; 2008 Jan; 37(1):35-9. PubMed ID: 18509983
    [Abstract] [Full Text] [Related]

  • 5. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA, Jin L, Wollan PC, Thompson GB, van Heerden J, Lloyd RV.
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [Abstract] [Full Text] [Related]

  • 6. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
    Ceyran AB, Şenol S, Şimşek BÇ, Sağıroğlu J, Aydın A.
    Int J Clin Exp Pathol; 2015 Feb; 8(4):3670-80. PubMed ID: 26097548
    [Abstract] [Full Text] [Related]

  • 7. Improvement of the cytological diagnostic accuracy of follicular thyroid lesions by the use of the Ki-67 proliferative index in addition to cytokeratin-19 and HBME-1 immunomarkers: a study of 61 cases of liquid-based FNA cytology with histological controls.
    Lacoste-Collin L, d'Aure D, Bérard E, Rouquette I, Delisle MB, Courtade-Saïdi M.
    Cytopathology; 2014 Jun; 25(3):160-9. PubMed ID: 24460983
    [Abstract] [Full Text] [Related]

  • 8. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms.
    Bejarano PA, Nikiforov YE, Swenson ES, Biddinger PW.
    Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):189-94. PubMed ID: 10981870
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical diagnosis of papillary thyroid carcinoma.
    Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL.
    Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules.
    Mai KT, Ford JC, Yazdi HM, Perkins DG, Commons AS.
    Pathol Res Pract; 2000 Apr; 196(8):533-40. PubMed ID: 10982016
    [Abstract] [Full Text] [Related]

  • 11. Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules.
    Beesley MF, McLaren KM.
    Histopathology; 2002 Sep; 41(3):236-43. PubMed ID: 12207785
    [Abstract] [Full Text] [Related]

  • 12. Histological and immunohistochemical aspects of papillary thyroid cancer.
    Radu TG, Mogoantă L, Busuioc CJ, Stănescu C, Grosu F.
    Rom J Morphol Embryol; 2015 Sep; 56(2 Suppl):789-95. PubMed ID: 26429174
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcription factor-1, and E-cadherin in thyroid carcinomas.
    Choi YL, Kim MK, Suh JW, Han J, Kim JH, Yang JH, Nam SJ.
    J Korean Med Sci; 2005 Oct; 20(5):853-9. PubMed ID: 16224162
    [Abstract] [Full Text] [Related]

  • 15. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
    Teng XD, Wang LJ, Yao HT, Li J, Ding W, Yan LP.
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Application value of fine needle aspiration and cell block in preoperative diagnosis of thyroid cancer and discrimination of follicular tumor].
    Fang Q, Cai C, Chen H.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug; 50(8):668-72. PubMed ID: 26696207
    [Abstract] [Full Text] [Related]

  • 19. [Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
    Schröder S, Wodzynski A, Padberg B.
    Pathologe; 1996 Nov; 17(6):425-32. PubMed ID: 9082363
    [Abstract] [Full Text] [Related]

  • 20. Is BECLIN-1 Immunoreactivity More Effective than HBME-1 in Diagnosis of Papillary Thyroid Cancer?
    Yeşil C, Kandemir O, Haksever H, Dabakoğlu T.
    Acta Chir Belg; 2015 Nov; 115(4):299-305. PubMed ID: 26324033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.